Table 1.
FDG-SUVR in the ROIs of cortex and subcortex before and after dopaminergic treatment.
| ROIs | FDG-SUVR cerebellum | Improvement | |
|---|---|---|---|
| Before | After | After/Before (%) | |
| Frontal lobe | |||
| Left | 1.35 | 1.59 | 118.52% |
| Right | 1.37 | 1.86 | 135.79% |
| Parietal lobe | |||
| · | 1.20 | 1.58 | 131.36% |
| Right | 1.27 | 1.63 | 127.84% |
| Temporal lobe | |||
| Left | 1.13 | 1.43 | 126.39% |
| Right | 1.09 | 1.49 | 135.83% |
| Occipital lobe | |||
| Left | 1.08 | 1.37 | 127.28% |
| Right | 1.31 | 1.83 | 139.42% |
| Cingulate gyrus | |||
| — | 1.24 | 1.68 | 135.57% |
| Putamen | |||
| Left | 1.67 | 2.20 | 131.59% |
| Right | 1.47 | 2.18 | 149.07% |
| Caudate nucleus | |||
| Left | 1.52 | 2.19 | 144.15% |
| Right | 1.77 | 2.20 | 124.07% |
| Thalamus | |||
| — | 1.49 | 2.20 | 148.22% |
| Midbrain | |||
| — | 1.35 | 1.88 | 140.07% |
SUVR, standard uptake value ratio; ROI, regions of interest.